{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:45:08Z","timestamp":1786463108782,"version":"build-2736575974"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s13760-026-03070-4","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T09:54:49Z","timestamp":1776678889000},"page":"1291-1309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stage-dependent associations of plasma clusterin with reduced brain volume, tau pathology, and cognitive impairment across the Alzheimer\u2019s disease spectrum"],"prefix":"10.1007","volume":"126","author":[{"given":"Qamar","family":"Abuhassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6903-9929","authenticated-orcid":false,"given":"Mustafa T.","family":"Ardah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya V.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmidhar","family":"Maharana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Inbathamizh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aashna","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevginoz","family":"Khodzhiyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"For the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"1","key":"3070_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00840-1","volume":"20","author":"X Zhao","year":"2025","unstructured":"Zhao X, Li Y, Zhang S, Sudwarts A, Zhang H, Kozlova A et al (2025) Alzheimer\u2019s disease protective allele of clusterin modulates neuronal excitability through lipid-droplet-mediated neuron-glia communication. Mol Neurodegener 20(1):51. https:\/\/doi.org\/10.1186\/s13024-025-00840-1","journal-title":"Mol Neurodegener"},{"issue":"7","key":"3070_CR2","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.4103\/1673-5374.301013","volume":"16","author":"H-J Moon","year":"2021","unstructured":"Moon H-J, Herring SK, Zhao L (2021) Clusterin: a multifaceted protein in the brain. Neural Regen Res 16(7):1438\u20131439","journal-title":"Neural Regen Res"},{"issue":"23","key":"3070_CR3","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1007\/s00018-011-0684-8","volume":"68","author":"AR Wyatt","year":"2011","unstructured":"Wyatt AR, Yerbury JJ, Berghofer P, Greguric I, Katsifis A, Dobson CM et al (2011) Clusterin facilitates in vivo clearance of extracellular misfolded proteins. Cell Mol Life Sci 68(23):3919\u201331. https:\/\/doi.org\/10.1007\/s00018-011-0684-8","journal-title":"Cell Mol Life Sci"},{"key":"3070_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111174","volume":"134","author":"C Rodr\u00edguez-Rivera","year":"2021","unstructured":"Rodr\u00edguez-Rivera C, Garcia MM, Molina-\u00c1lvarez M, Gonz\u00e1lez-Mart\u00edn C, Goicoechea C (2021) Clusterin: always protecting. Synthesis, function and potential issues. Biomed Pharmacother 134:111174. https:\/\/doi.org\/10.1016\/j.biopha.2020.111174","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"3070_CR5","doi-asserted-by":"publisher","first-page":"10073","DOI":"10.1074\/jbc.M110.190546","volume":"286","author":"S Materia","year":"2011","unstructured":"Materia S, Cater MA, Klomp LW, Mercer JF, La Fontaine S (2011) Clusterin (apolipoprotein J), a molecular chaperone that facilitates degradation of the copper-ATPases ATP7A and ATP7B. J Biol Chem 286(12):10073\u201310083. https:\/\/doi.org\/10.1074\/jbc.M110.190546","journal-title":"J Biol Chem"},{"issue":"7","key":"3070_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/archgenpsychiatry.2010.78","volume":"67","author":"M Thambisetty","year":"2010","unstructured":"Thambisetty M, Simmons A, Velayudhan L, Hye A, Campbell J, Zhang Y et al (2010) Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry 67(7):739\u201348. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2010.78","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"3070_CR7","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet 41(10):1088\u201393. https:\/\/doi.org\/10.1038\/ng.440","journal-title":"Nat Genet"},{"issue":"3","key":"3070_CR8","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.neurobiolaging.2010.04.015","volume":"33","author":"MI Kamboh","year":"2012","unstructured":"Kamboh MI, Minster RL, Demirci FY, Ganguli M, DeKosky ST, Lopez OL et al (2012) Association of CLU and PICALM variants with Alzheimer\u2019s disease. Neurobiol Aging 33(3):518\u201321. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.04.015","journal-title":"Neurobiol Aging"},{"issue":"3","key":"3070_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/bpa.12392","volume":"27","author":"JS Miners","year":"2017","unstructured":"Miners JS, Clarke P, Love S (2017) Clusterin levels are increased in Alzheimer\u2019s disease and influence the regional distribution of A\u03b2. Brain Pathol 27(3):305\u2013313. https:\/\/doi.org\/10.1111\/bpa.12392","journal-title":"Brain Pathol"},{"key":"3070_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00164","volume":"13","author":"EM Foster","year":"2019","unstructured":"Foster EM, Dangla-Valls A, Lovestone S, Ribe EM, Buckley NJ (2019) Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies. Front Neurosci 13:164. https:\/\/doi.org\/10.3389\/fnins.2019.00164","journal-title":"Front Neurosci"},{"key":"3070_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166384","volume":"1868","author":"P Spatharas","year":"2022","unstructured":"Spatharas P, Nasi G, Tsiolaki P, Theodoropoulou M, Papandreou N, Hoenger A et al (2022) Clusterin in Alzheimer\u2019s disease: an amyloidogenic inhibitor of amyloid formation? Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1868:166384. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166384","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"12","key":"3070_CR12","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.neuron.2025.03.034","volume":"113","author":"AM Lish","year":"2025","unstructured":"Lish AM, Grogan EFL, Benoit CR, Pearse RV II, Heuer SE, Luquez T et al (2025) CLU alleviates Alzheimer\u2019s disease-relevant processes by modulating astrocyte reactivity and microglia-dependent synaptic density. Neuron 113(12):1925\u201346.e11. https:\/\/doi.org\/10.1016\/j.neuron.2025.03.034","journal-title":"Neuron"},{"issue":"1","key":"3070_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neuroimage.2011.07.056","volume":"59","author":"M Thambisetty","year":"2012","unstructured":"Thambisetty M, An Y, Kinsey A, Koka D, Saleem M, G\u00fcntert A et al (2012) Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment. Neuroimage 59(1):212\u20137. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.07.056","journal-title":"Neuroimage"},{"key":"3070_CR14","doi-asserted-by":"publisher","unstructured":"Vishnu V, Modi M, Mohanty M, Khandelwal N, Mittal B, Prabhakar S (2015) Role of plasma clusterin in Mild cognitive impairment, Alzheimer\u2019s disease and Vascular dementia (P5.027). Neurology. 84(14_supplement):P5.027. https:\/\/doi.org\/10.1212\/WNL.84.14_supplement.P5.027","DOI":"10.1212\/WNL.84.14_supplement.P5.027"},{"issue":"1","key":"3070_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11011-018-0325-0","volume":"34","author":"C Yang","year":"2019","unstructured":"Yang C, Wang H, Li C, Niu H, Luo S, Guo X (2019) Association between clusterin concentration and dementia: a systematic review and meta-analysis. Metab Brain Dis 34(1):129\u2013140. https:\/\/doi.org\/10.1007\/s11011-018-0325-0","journal-title":"Metab Brain Dis"},{"key":"3070_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1256389","volume":"15","author":"H Wang","year":"2023","unstructured":"Wang H, Ma LZ, Sheng ZH, Liu JY, Yuan WY, Guo F et al (2023) Association between cerebrospinal fluid clusterin and biomarkers of Alzheimer\u2019s disease pathology in mild cognitive impairment: a longitudinal cohort study. Front Aging Neurosci 15:1256389. https:\/\/doi.org\/10.3389\/fnagi.2023.1256389","journal-title":"Front Aging Neurosci"},{"issue":"12","key":"3070_CR17","doi-asserted-by":"publisher","first-page":"8279","DOI":"10.1002\/alz.14242","volume":"20","author":"M Rivera Mindt","year":"2024","unstructured":"Rivera Mindt M, Arentoft A, Calcetas AT, Guzman VA, Amaza H, Ajayi A et al (2024) The Alzheimer\u2019s Disease Neuroimaging Initiative-4 (ADNI-4) engagement core: a culturally informed, community-engaged research (CI-CER) model to advance brain health equity. Alzheimer\u2019s & Dementia 20(12):8279\u201393. https:\/\/doi.org\/10.1002\/alz.14242","journal-title":"Alzheimer's & Dementia"},{"key":"3070_CR18","unstructured":"Alzheimer\u2019s Disease Neuroimaging Initiative 3 (ADNI3). https:\/\/clinicaltrials.stanford.edu\/trials\/a\/NCT02854033.html?utm Accessed"},{"issue":"9","key":"3070_CR19","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/j.1532-5415.1992.tb01992.x","volume":"40","author":"TN Tombaugh","year":"1992","unstructured":"Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40(9):922\u2013935","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"3070_CR20","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/psyg.13069","volume":"24","author":"QC Truong","year":"2024","unstructured":"Truong QC, Cervin M, Choo CC, Numbers K, Bentvelzen AC, Kochan NA et al (2024) Examining the validity of the Mini-Mental State Examination (MMSE) and its domains using network analysis. Psychogeriatrics 24(2):259\u2013271","journal-title":"Psychogeriatrics"},{"issue":"6","key":"3070_CR21","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jalz.2011.01.005","volume":"7","author":"N Coley","year":"2011","unstructured":"Coley N, Andrieu S, Jaros M, Weiner M, Cedarbaum J, Vellas B (2011) Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer\u2019s disease trials. Alzheimer\u2019s Dement 7(6):602\u2013610 e2","journal-title":"Alzheimer\u2019s Dement"},{"issue":"3\u20134","key":"3070_CR22","first-page":"637","volume":"24","author":"L Berg","year":"1989","unstructured":"Berg L (1989) Clinical dementia rating (CDR) \u00b9. Psychopharmacol Bull 24(3\u20134):637","journal-title":"Psychopharmacol Bull"},{"issue":"8","key":"3070_CR23","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1001\/archneur.65.8.1091","volume":"65","author":"SE O\u2019Bryant","year":"2008","unstructured":"O\u2019Bryant SE, Waring SC, Cullum CM, Hall J, Lacritz L, Massman PJ et al (2008) Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer\u2019s research consortium study. Arch Neurol 65(8):1091\u20131095","journal-title":"Arch Neurol"},{"key":"3070_CR24","doi-asserted-by":"crossref","unstructured":"Nogueira J, Freitas S, Duro D, Tabuas-Pereira M, Guerreiro M, Almeida J et al (2018) Alzheimer\u2019s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Normative Data for the Portuguese Population. Acta Med Port, 31(2)","DOI":"10.20344\/amp.8859"},{"issue":"2","key":"3070_CR25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1017\/S1041610296002578","volume":"8","author":"RC Mohs","year":"1996","unstructured":"Mohs RC (1996) The Alzheimer\u2019s disease assessment scale. Int Psychogeriatr 8(2):195\u2013203","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"3070_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14264","volume":"21","author":"LM Shaw","year":"2025","unstructured":"Shaw LM, Korecka M, Lee EB, Cousins KAQ, Vanderstichele H, Schindler SE et al (2025) ADNI biomarker core: a review of progress since 2004 and future challenges. Alzheimers Dement 21(1):e14264. https:\/\/doi.org\/10.1002\/alz.14264","journal-title":"Alzheimers Dement"},{"issue":"1","key":"3070_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.12315","volume":"14","author":"C Windon","year":"2022","unstructured":"Windon C, Iaccarino L, Mundada N, Allen I, Boxer AL, Byrd D et al (2022) Comparison of plasma and CSF biomarkers across ethnoracial groups in the ADNI. Alzheimers Dement Diagn Assess Dis Monit 14(1):e12315. https:\/\/doi.org\/10.1002\/dad2.12315","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"issue":"10","key":"3070_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70797","volume":"21","author":"E Manuilova","year":"2025","unstructured":"Manuilova E, Schrurs I, Rutz S, McIlwrick S, Goldhardt O, Sommer P et al (2025) Elecsys CSF AD immunoassays: sample stability for a new pre-analytical protocol for fresh CSF. Alzheimers Dement 21(10):e70797. https:\/\/doi.org\/10.1002\/alz.70797","journal-title":"Alzheimers Dement"},{"issue":"4","key":"3070_CR29","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/jmri.21049","volume":"27","author":"CR Jack Jr","year":"2008","unstructured":"Jack CR Jr., Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D et al (2008) The Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 27(4):685\u2013691. https:\/\/doi.org\/10.1002\/jmri.21049","journal-title":"J Magn Reson Imaging"},{"issue":"7","key":"3070_CR30","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jalz.2015.05.003","volume":"11","author":"JH Kang","year":"2015","unstructured":"Kang JH, Korecka M, Figurski MJ, Toledo JB, Blennow K, Zetterberg H et al (2015) The Alzheimer\u2019s disease neuroimaging initiative 2 biomarker core: a review of progress and plans. Alzheimers Dement 11(7):772\u201391. https:\/\/doi.org\/10.1016\/j.jalz.2015.05.003","journal-title":"Alzheimers Dement"},{"issue":"10","key":"3070_CR31","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.1002\/alz.14166","volume":"20","author":"CR Jr. Jack","year":"2024","unstructured":"Jack CR Jr., Arani A, Borowski BJ, Cash DM, Crawford K, Das SR et al (2024) Overview of ADNI MRI. Alzheimers Dement 20(10):7350\u201360. https:\/\/doi.org\/10.1002\/alz.14166","journal-title":"Alzheimers Dement"},{"issue":"9","key":"3070_CR32","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2174\/15672050113106660162","volume":"10","author":"GM Mullan","year":"2013","unstructured":"Mullan GM, McEneny J, Fuchs M, McMaster C, Todd S, McGuinness B et al (2013) Plasma clusterin levels and the rs11136000 genotype in individuals with mild cognitive impairment and Alzheimer\u2019s disease. Curr Alzheimer Res 10(9):973\u20138. https:\/\/doi.org\/10.2174\/15672050113106660162","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"3070_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05390-1","volume":"7","author":"JL Hsu","year":"2017","unstructured":"Hsu JL, Lee WJ, Liao YC, Lirng JF, Wang SJ, Fuh JL (2017) Plasma biomarkers are associated with agitation and regional brain atrophy in Alzheimer\u2019s disease. Sci Rep 7(1):5035. https:\/\/doi.org\/10.1038\/s41598-017-05390-1","journal-title":"Sci Rep"},{"issue":"11","key":"3070_CR34","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.2174\/1567205016666191024141757","volume":"16","author":"X Shi","year":"2019","unstructured":"Shi X, Xie B, Xing Y, Tang Y (2019) Plasma clusterin as a potential biomarker for Alzheimer\u2019s disease-a systematic review and meta-analysis. Curr Alzheimer Res 16(11):1018\u20131027. https:\/\/doi.org\/10.2174\/1567205016666191024141757","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"3070_CR35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jamaneurol.2013.4560","volume":"71","author":"RS Desikan","year":"2014","unstructured":"Desikan RS, Thompson WK, Holland D, Hess CP, Brewer JB, Zetterberg H et al (2014) The role of clusterin in amyloid-\u03b2-associated neurodegeneration. JAMA Neurol 71(2):180\u20137. https:\/\/doi.org\/10.1001\/jamaneurol.2013.4560","journal-title":"JAMA Neurol"},{"key":"3070_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1256389","author":"H Wang","year":"2023","unstructured":"Wang H, Ma L-Z, Sheng Z-H, Liu J-Y, Yuan W-Y, Guo F et al (2023) Association between cerebrospinal fluid clusterin and biomarkers of Alzheimer\u2019s disease pathology in mild cognitive impairment: a longitudinal cohort study. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2023.1256389","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"3070_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190478","volume":"13","author":"T Haight","year":"2018","unstructured":"Haight T, Bryan RN, Meirelles O, Tracy R, Fornage M, Richard M et al (2018) Associations of plasma clusterin and Alzheimer\u2019s disease-related MRI markers in adults at mid-life: the CARDIA brain MRI sub-study. PLoS One 13(1):e0190478","journal-title":"PLoS One"},{"issue":"4","key":"3070_CR38","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3233\/jad-150036","volume":"46","author":"W Jongbloed","year":"2015","unstructured":"Jongbloed W, van Dijk KD, Mulder SD, van de Berg WD, Blankenstein MA, van der Flier W et al (2015) Clusterin levels in plasma predict cognitive decline and progression to Alzheimer\u2019s disease. J Alzheimers Dis 46(4):1103\u201310. https:\/\/doi.org\/10.3233\/jad-150036","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"3070_CR39","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neuroimage.2011.07.056","volume":"59","author":"M Thambisetty","year":"2012","unstructured":"Thambisetty M, An Y, Kinsey A, Koka D, Saleem M, G\u03cbntert A et al (2012) Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment. Neuroimage 59(1):212\u20137. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.07.056","journal-title":"Neuroimage"},{"key":"3070_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.dadm.2016.06.005","volume":"3","author":"G Weinstein","year":"2016","unstructured":"Weinstein G, Beiser AS, Preis SR, Courchesne P, Chouraki V, Levy D et al (2016) Plasma clusterin levels and risk of dementia, Alzheimer\u2019s disease, and stroke. Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit 3:103\u2013109. https:\/\/doi.org\/10.1016\/j.dadm.2016.06.005","journal-title":"Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit"},{"key":"3070_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00164","author":"EM Foster","year":"2019","unstructured":"Foster EM, Dangla-Valls A, Lovestone S, Ribe EM, Buckley NJ (2019) Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2019.00164","journal-title":"Front Neurosci"},{"issue":"1","key":"3070_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-01079-1","volume":"8","author":"AM Wojtas","year":"2020","unstructured":"Wojtas AM, Carlomagno Y, Sens JP, Kang SS, Jensen TD, Kurti A et al (2020) Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation. Acta Neuropathol Commun 8(1):210. https:\/\/doi.org\/10.1186\/s40478-020-01079-1","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"3070_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25060-1","volume":"12","author":"P Yuste-Checa","year":"2021","unstructured":"Yuste-Checa P, Trinkaus VA, Riera-Tur I, Imamoglu R, Schaller TF, Wang H et al (2021) The extracellular chaperone clusterin enhances Tau aggregate seeding in a cellular model. Nat Commun 12(1):4863. https:\/\/doi.org\/10.1038\/s41467-021-25060-1","journal-title":"Nat Commun"},{"key":"3070_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157271","author":"Y Yu","year":"2025","unstructured":"Yu Y, Wang C, Wang B, Wang X, Zhao Q, Yan Y et al (2025) Clusterin regulates the mechanisms of neuroinflammation and neuronal circuit impairment in Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26157271","journal-title":"Int J Mol Sci"},{"key":"3070_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0481-1","author":"J Gregory","year":"2017","unstructured":"Gregory J, Whiten D, Brown R, Pereira de Barros T, Kumita J, Yerbury J et al (2017) Clusterin protects neurons against intracellular proteotoxicity. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/s40478-017-0481-1","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"3070_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166384","volume":"1868","author":"PM Spatharas","year":"2022","unstructured":"Spatharas PM, Nasi GI, Tsiolaki PL, Theodoropoulou MK, Papandreou NC, Hoenger A et al (2022) Clusterin in Alzheimer\u2019s disease: an amyloidogenic inhibitor of amyloid formation? Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1868(7):166384. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166384","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"10","key":"3070_CR47","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1038\/s41594-025-01631-4","volume":"32","author":"P Yuste-Checa","year":"2025","unstructured":"Yuste-Checa P, Carvajal AI, Mi C, Paatz S, Hartl FU, Bracher A (2025) Structural analyses define the molecular basis of clusterin chaperone function. Nat Struct Mol Biol 32(10):2035\u20132045. https:\/\/doi.org\/10.1038\/s41594-025-01631-4","journal-title":"Nat Struct Mol Biol"},{"issue":"11","key":"3070_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050237","volume":"7","author":"E Silajd\u017ei\u0107","year":"2012","unstructured":"Silajd\u017ei\u0107 E, Minthon L, Bj\u00f6rkqvist M, Hansson O (2012) No diagnostic value of plasma clusterin in Alzheimer\u2019s disease. PLoS One 7(11):e50237. https:\/\/doi.org\/10.1371\/journal.pone.0050237","journal-title":"PLoS One"},{"issue":"1","key":"3070_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/srep15546","volume":"5","author":"Y Meng","year":"2015","unstructured":"Meng Y, Li H, Hua R, Wang H, Lu J, Yu X et al (2015) A correlativity study of plasma APL1\u03b228 and clusterin levels with MMSE\/MoCA\/CASI in aMCI patients. Sci Rep 5(1):15546. https:\/\/doi.org\/10.1038\/srep15546","journal-title":"Sci Rep"},{"issue":"1","key":"3070_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190478","volume":"13","author":"T Haight","year":"2018","unstructured":"Haight T, Bryan RN, Meirelles O, Tracy R, Fornage M, Richard M et al (2018) Associations of plasma clusterin and Alzheimer\u2019s disease-related MRI markers in adults at mid-life: The CARDIA brain MRI sub-study. PLoS One 13(1):e0190478. https:\/\/doi.org\/10.1371\/journal.pone.0190478","journal-title":"PLoS One"},{"issue":"2","key":"3070_CR51","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nrneurol.2014.1","volume":"10","author":"H Malkki","year":"2014","unstructured":"Malkki H (2014) Chaperone protein clusterin is involved in amyloid-\u03b2-associated entorhinal atrophy in early AD. Nat Rev Neurol 10(2):60. https:\/\/doi.org\/10.1038\/nrneurol.2014.1","journal-title":"Nat Rev Neurol"},{"key":"3070_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00504","author":"JP Robbins","year":"2018","unstructured":"Robbins JP, Perfect L, Ribe EM, Maresca M, Dangla-Valls A, Foster EM et al (2018) Clusterin is required for \u03b2-amyloid toxicity in human iPSC-derived neurons. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2018.00504","journal-title":"Front Neurosci"},{"issue":"1","key":"3070_CR53","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.neuroimage.2011.07.056","volume":"59","author":"M Thambisetty","year":"2012","unstructured":"Thambisetty M, An Y, Kinsey A, Koka D, Saleem M, G\u03cbntert A et al (2012) Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment. Neuroimage 59(1):212\u20137","journal-title":"Neuroimage"},{"issue":"1","key":"3070_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nsmb.2191","volume":"19","author":"P Narayan","year":"2011","unstructured":"Narayan P, Orte A, Clarke RW, Bolognesi B, Hook S, Ganzinger KA et al (2011) The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-\u03b2(1\u201340) peptide. Nat Struct Mol Biol 19(1):79\u201383. https:\/\/doi.org\/10.1038\/nsmb.2191","journal-title":"Nat Struct Mol Biol"},{"issue":"10","key":"3070_CR55","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1096\/fj.06-7986com","volume":"21","author":"JJ Yerbury","year":"2007","unstructured":"Yerbury JJ, Poon S, Meehan S, Thompson B, Kumita JR, Dobson CM et al (2007) The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J 21(10):2312\u201322. https:\/\/doi.org\/10.1096\/fj.06-7986com","journal-title":"FASEB J"},{"issue":"1","key":"3070_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2896","volume":"4","author":"SY Gil","year":"2013","unstructured":"Gil SY, Youn B-S, Byun K, Huang H, Namkoong C, Jang P-G et al (2013) Clusterin and LRP2 are critical components of the hypothalamic feeding regulatory pathway. Nat Commun 4(1):1862. https:\/\/doi.org\/10.1038\/ncomms2896","journal-title":"Nat Commun"},{"issue":"1","key":"3070_CR57","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4067\/S0716-97602011000100012","volume":"44","author":"M-P Marzolo","year":"2011","unstructured":"Marzolo M-P, Farf\u00e1n P (2011) New insights into the roles of megalin\/LRP2 and the regulation of its functional expression. Biol Res 44(1):89\u2013105","journal-title":"Biol Res"},{"issue":"2","key":"3070_CR58","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/bpa.12660","volume":"29","author":"SB Oh","year":"2019","unstructured":"Oh SB, Kim MS, Park S, Son H, Kim SY, Kim MS et al (2019) Clusterin contributes to early stage of Alzheimer\u2019s disease pathogenesis. Brain Pathol 29(2):217\u201331. https:\/\/doi.org\/10.1111\/bpa.12660","journal-title":"Brain Pathol"},{"issue":"1","key":"3070_CR59","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12264-013-1391-2","volume":"30","author":"X Li","year":"2014","unstructured":"Li X, Ma Y, Wei X, Li Y, Wu H, Zhuang J et al (2014) Clusterin in Alzheimer\u2019s disease: a player in the biological behavior of amyloid-beta. Neurosci Bull 30(1):162\u2013168","journal-title":"Neurosci Bull"},{"issue":"1","key":"3070_CR60","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/exnr.1995.1080","volume":"136","author":"T Oda","year":"1995","unstructured":"Oda T, Wals P, Osterburg HH, Johnson SA, Pasinetti GM, Morgan TE et al (1995) Clusterin (apoJ) alters the aggregation of amyloid \u03b2-peptide (A\u03b21\u201342) and forms slowly sedimenting A\u03b2 complexes that cause oxidative stress. Exp Neurol 136(1):22\u201331","journal-title":"Exp Neurol"},{"issue":"3","key":"3070_CR61","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/bpa.12392","volume":"27","author":"JS Miners","year":"2017","unstructured":"Miners JS, Clarke P, Love S (2017) Clusterin levels are increased in A lzheimer\u2019s disease and influence the regional distribution of A\u03b2. Brain Pathol 27(3):305\u2013313","journal-title":"Brain Pathol"},{"issue":"2","key":"3070_CR62","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jamaneurol.2013.4560","volume":"71","author":"RS Desikan","year":"2014","unstructured":"Desikan RS, Thompson WK, Holland D, Hess CP, Brewer JB, Zetterberg H et al (2014) The role of clusterin in amyloid-\u03b2\u2013associated neurodegeneration. JAMA Neurol 71(2):180\u20137","journal-title":"JAMA Neurol"},{"issue":"1","key":"3070_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-024-01118-1","volume":"17","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi A (2024) The duality of amyloid-\u03b2: its role in normal and Alzheimer\u2019s disease states. Mol Brain 17(1):44. https:\/\/doi.org\/10.1186\/s13041-024-01118-1","journal-title":"Mol Brain"},{"issue":"1","key":"3070_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-025-01229-3","volume":"18","author":"A Azargoonjahromi","year":"2025","unstructured":"Azargoonjahromi A, Nasiri H, Alzheimer\u2019s Disease Neuroimaging I (2025) CSF amyloid-\u03b242 associates with neuropsychiatric and cognitive outcomes via cerebral glucose metabolism. Mol Brain 18(1):55. https:\/\/doi.org\/10.1186\/s13041-025-01229-3","journal-title":"Mol Brain"},{"key":"3070_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/biom12101452","author":"MM Fareed","year":"2022","unstructured":"Fareed MM, Qasmi M, Aziz S, V\u00f6lker E, F\u00f6rster CY, Shityakov S (2022) The role of clusterin transporter in the pathogenesis of Alzheimer\u2019s disease at the blood-brain barrier interface: a systematic review. Biomolecules. https:\/\/doi.org\/10.3390\/biom12101452","journal-title":"Biomolecules"},{"issue":"4","key":"3070_CR66","doi-asserted-by":"publisher","first-page":"100488","DOI":"10.1016\/j.phyplu.2023.100488","volume":"3","author":"M Barakat","year":"2023","unstructured":"Barakat M, Syed NK, Hasen E, Abdulrazzaq SB, Thiab S, Al-Najjar MA et al (2023) The effect of natural products on inflammatory cytokines production and secretion. Phytomedicine Plus 3(4):100488","journal-title":"Phytomedicine Plus"},{"issue":"1","key":"3070_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56622-0","volume":"14","author":"MA Al-Najjar","year":"2024","unstructured":"Al-Najjar MA, Abdulrazzaq SB, Alzaghari LF, Mahmod AI, Omar A, Hasen E et al (2024) Evaluation of immunomodulatory potential of probiotic conditioned medium on murine macrophages. Sci Rep 14(1):7126","journal-title":"Sci Rep"},{"key":"3070_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.phyplu.2025.100876","volume":"5","author":"M Barakat","year":"2025","unstructured":"Barakat M, Thiab S, Alzaghari L, Abdulrazzaq S, Hasen E, Feras Abuarab S et al (2025) Cannabis and the immune response: a comprehensive review of therapeutic potential and concerns. Phytomedicine Plus 5:100876. https:\/\/doi.org\/10.1016\/j.phyplu.2025.100876","journal-title":"Phytomedicine Plus"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03070-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-026-03070-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03070-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T13:38:05Z","timestamp":1786455485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-026-03070-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["3070"],"URL":"https:\/\/doi.org\/10.1007\/s13760-026-03070-4","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"25 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted using ADNI data. The ADNI study is ethically approved and operated in accordance with the Declaration of Helsinki, 1964.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}